Predicting hospital surge after a large-scale anthrax attack: a model-based analysis of CDC's cities readiness initiative prophylaxis recommendations
- PMID: 19617582
- DOI: 10.1177/0272989X09341389
Predicting hospital surge after a large-scale anthrax attack: a model-based analysis of CDC's cities readiness initiative prophylaxis recommendations
Abstract
Background: A CRI-compliant prophylaxis campaign starting 2 days after exposure would protect from 86% to 87% of exposed individuals from illness (assuming, in the base case, 90% antibiotic effectiveness and a 95% attack rate). Each additional day needed to complete the campaign would result in, on average, 2.4% to 2.9% more hospitalizations in the exposed population; each additional day's delay to initiating prophylaxis beyond 2 days would result in 5.2% to 6.5% additional hospitalizations. These population protection estimates vary roughly proportionally to antibiotic effectiveness but are relatively insensitive to variations in anthrax incubation period.
Conclusion: . Delays in detecting and initiating response to large-scale, covert aerosol anthrax releases in a major city would render even highly effective CRI-compliant mass prophylaxis campaigns unable to prevent unsustainable levels of surge hospitalizations. Although outcomes may improve with more rapid epidemiological identification of affected subpopulations and increased collaboration across regional public health and hospital systems, these findings support an increased focus on prevention of this public health threat.
Similar articles
-
Anticipating demand for emergency health services due to medication-related adverse events after rapid mass prophylaxis campaigns.Acad Emerg Med. 2007 Mar;14(3):268-74. doi: 10.1197/j.aem.2006.08.017. Epub 2006 Dec 27. Acad Emerg Med. 2007. PMID: 17192445
-
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):393-401. doi: 10.1002/pds.1085. Pharmacoepidemiol Drug Saf. 2005. PMID: 15717323
-
Lessons learned from the CDC's post-exposure prophylaxis program following the anthrax attacks of 2001.Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):389-91. doi: 10.1002/pds.1086. Pharmacoepidemiol Drug Saf. 2005. PMID: 15924332 No abstract available.
-
[Anthrax--an overview at 2002].Harefuah. 2002 May;141 Spec No:63-72, 121, 120. Harefuah. 2002. PMID: 12170557 Review. Hebrew.
-
Vaccines and bioterrorism: smallpox and anthrax.J Fam Pract. 2003 Jan;52(1 Suppl):S56-61. J Fam Pract. 2003. PMID: 12556279 Review.
Cited by
-
Anthrax: A narrative review.New Microbes New Infect. 2024 Oct 10;62:101501. doi: 10.1016/j.nmni.2024.101501. eCollection 2024 Dec. New Microbes New Infect. 2024. PMID: 39497912 Free PMC article. Review.
-
Algorithms for the Identification of Anthrax Meningitis During a Mass Casualty Event Based on a Systematic Review of Systemic Anthrax From 1880 Through 2018.Clin Infect Dis. 2022 Oct 17;75(Suppl 3):S468-S477. doi: 10.1093/cid/ciac546. Clin Infect Dis. 2022. PMID: 36251554 Free PMC article.
-
Best practice assessment of disease modelling for infectious disease outbreaks.Epidemiol Infect. 2018 Jul;146(10):1207-1215. doi: 10.1017/S095026881800119X. Epub 2018 May 8. Epidemiol Infect. 2018. PMID: 29734964 Free PMC article. Review.
-
Modeling Tool for Decision Support during Early Days of an Anthrax Event.Emerg Infect Dis. 2017 Jan;23(1):46-55. doi: 10.3201/eid2301.151787. Emerg Infect Dis. 2017. PMID: 27983505 Free PMC article.
-
A review of back-calculation techniques and their potential to inform mitigation strategies with application to non-transmissible acute infectious diseases.J R Soc Interface. 2015 May 6;12(106):20150096. doi: 10.1098/rsif.2015.0096. J R Soc Interface. 2015. PMID: 25977955 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
